Manulife (Manufacturers Life Insurance)’s Spero Therapeutics SPRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-11,620
Closed -$101K 3127
2022
Q1
$101K Sell
11,620
-2,436
-17% -$21.2K ﹤0.01% 2956
2021
Q4
$225 Sell
14,056
-220
-2% -$4 ﹤0.01% 2828
2021
Q3
$263K Sell
14,276
-1,665
-10% -$30.7K ﹤0.01% 2778
2021
Q2
$223K Buy
15,941
+2,484
+18% +$34.7K ﹤0.01% 3026
2021
Q1
$198K Buy
13,457
+91
+0.7% +$1.34K ﹤0.01% 2899
2020
Q4
$259K Buy
+13,366
New +$259K ﹤0.01% 2605
2018
Q3
Sell
-664
Closed -$10K 3778
2018
Q2
$10K Sell
664
-62
-9% -$934 ﹤0.01% 3891
2018
Q1
$10K Sell
726
-402
-36% -$5.54K ﹤0.01% 3928
2017
Q4
$13K Buy
+1,128
New +$13K ﹤0.01% 3915